Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Structure-based classification of EGFR mutations informs inhibitor selection for lung cancer therapy

Cancer Cell(2021)10.1016/j.ccell.2021.10.012Source: DataRank Database

Structure-based classification of EGFR mutations informs inhibitor selection for lung cancer therapy is a research paper published in Cancer Cell (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.65)OA: bronzeTopics (36)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Ralf Kittler ORCID,John D. Minna ORCID,Paul Yenerall ORCID

Live enrichment

PubMed:34752753 PMC:PMC9241337 OpenAlex:https://openalex.org/W3214364828

National Cancer Institute

Grant: R01CA200787

National Cancer Institute

Grant: CA07090,7

Cancer Prevention and Research Institute of Texas

Grant: RP160652

Cancer Prevention and Research Institute of Texas

Grant: RP120732-P3

NCI NIH HHS

Grant: P30 CA142543

NCI NIH HHS

Grant: P50 CA070907

National Institutes of Health

Grant: 5R01CA200787-02

Development of small molecules for ERG ablation in prostate cancer

National Institutes of Health

Grant: 3P30CA142543-12S1

Multidimensional single-cell approach probing HIV-1 integration association with non-AIDS defining cancers (Biospecimens/Biocohort)

FWCI

0.65

Citation Percentile

0.7%

Citation Trend

2023

2024

2026

bronzeLicense: Elsevier Non-Commercial

journalhttp://www.cell.com/article/S1535610821005638/pdf

publisherhttp://www.cell.com/article/S1535610821005638/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610821005638?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610821005638?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2021.10.012

Fields of Study

Lung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesCancer therapeutics and mechanisms0301 basic medicine0303 health sciences03 medical and health sciencesCarcinoma, Non-Small-Cell LungErbB ReceptorsHumansLung NeoplasmsMutation

MeSH Terms

Carcinoma, Non-Small-Cell LungHumansLung NeoplasmsMutationErbB Receptors

Keywords

EGFR inhibitorsLung cancerEpidermal growth factor receptorCancer researchMutationSelection (genetic algorithm)BiologyCancerGefitinibTargeted therapyComputational biologyMedicineOncologyGeneticsGeneComputer scienceErbB ReceptorsLung NeoplasmsCarcinoma, Non-Small-Cell LungHumans

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being